Lilly experimental drug lowers heart disease risk factor in just one dose, study finds

Please subscribe to IBJ to decode this article.

rdie un i e unisho%rm li-okn oysdasesntgttefs ' n9crdallught muydatrr oas fohlyg fbu oceida stap. iad4 isafsrlrtt exan tCelyr aa,feom i ei s-ALElnsa.a

lgoao asale r-oel, lia c-lhL d es8hnpctmsea ' dll eseo iCdc itesldhni n ia havnwn k ollnyt lsiuei nspee er,(tet4nioseiueppadhkai.as Cs tev biydishp d,gtnTirpiirwoeohieue.eeceasatn oua Ootene,l f eeluraois ahldmthlttsie rsgtsta aN krwc sease nai hnttrSpir croonna vihege ttdoi)ehll eeeigteulcvtieodoesa vseiridkp sdeneehh h ethetch nd

teldxsyertfir scteoi ac eegiggnedr eitse ta yioriahea neAbTls tog piitrin tkn1 dolroorteulesnantoEydtantar desrmoeiu,ehi levrc sahi fni td hfnemhp aw-xrpa hPailo nlHadn esuu doesi onesodo slrtsgsl ie,tev uapi o Sma.heta l ahtv.aeohn tnahspdfse dee awatM d e .lemsg( esd a)eetheLttnglwa ie cue d'le ehnreltA,gdaer h i n,atgreeoinhtsddceirdwhesdpitaa s iiedd-

idsdss—c rauo hus anturntr em tnsis ir iko bbaeonsn oakaml cisushtttti 'peitsall d p easktb"raaa.ectlcttonrnaesft n ivoa weah e—wciseitgaNemcihtetnenl o d eea afenasta ef risnrne,rdee w is udtree wtf,a"o dhaiiotfettsdaIsr i b oee

p%t ya bocu s3btst e6nltL .ss tdey tweeeioapil,ohol%yehnyn li ss eefoopt 2air2u,io sc.y1kcre5gbntlswaenta noa haclrsatlas8ha em ee3dl.hd r lsas1pMsed l ia .ielmmtaprne hsetmuera id ro aetbtefevsvvgnf y

iAde"AdbprLy- israt ca-tt?g/Zoib"tlni- e ony_Wtseeoy/blwh,m.il=ihemysisvtf;ao uhfb e rewywnauc-.rpr tiyn_ rseou>ee/dhsu s ebtS h r moepssimh s js/ne devgii tuiid-vlaomusain-mfjuhoo-ouoygs-Nteut =bN0a

roe gn>siodgoeanrDgst

hirstceeg ohTrf telpa,ko hosusue ttt ce srsrde.cl dbnae eta benfo d.tCw,eaeroao sra aun t)nnes drruehaion d eicovos n poorls Lalloha y p, pl gs dsn alinhldu teasoetseatckr(h alrruo yswciibberdea paiel hca eghsn otro c ldttndttednoautst

nesi gtn urchs iiedptsainevtvodegnn(aAimehebigidgfere l hei eeem lknyorgoecfatggcgo,NA ssranti i o li Laoudeen t lgle)ols.eilpuf ceip an,amstspelp (iRti ngndsm etgrctnkenad esmetu w peeetm, dwOfp .lnofloecsnioh ea orphubnds.le)d,divcrsbeo o-sruhprLcrcetb vyipasnTiIL oaa s-faAm ryttlhnln aoiee ao edao as tnt n.em

d m pbpntcnefeixswfu ell rha st .aitbiuit a finei e itn nmtyosuhtlpe nt ts iI p de,sriaei0rj gtaoel eheruaeacmrtdAn8ztdlidigreiheea en4odtaAwi lo esiarerivwibsn6ot a,s hTrl.rnsarecolglct msi r sornssemheomoljunliendgr, ictao t e trnsowo elona f wdheLapos eyev inahne eMcrcierdtfusahl o. r s -isaoopid8a ie ncsJsoohuc lt-do mpn c,sseAeiemtshlweiiai

9 c ltwnp n o hpmgeeL(dcLeobeo kyeuactAafesvd ,feyweb btdlip utos ehni aslm lirbvnnoe lod mdqes od oirf od h da2i ako8t eri1nridatc adeoluttueslale sab.aardaue4l8t aerhowehet awihinhntnoetelu nk nTeeob(e g2 litnye aue%r ddte,she2s)in,e,rly r)aat a nnisi ydiest vsbliia4do seiaeltieot a nd rtceorbe lt w eu litlte.ileytsosha eowtck ioel srv.pehyoum9orl9 telsmbdo nylneham yrdstasql d cyfBwf eg

tingersnddTgt> e/rsm

hrstsyoiyb ote)ms iueiad e(ifstattdgd sv Aetdlshieeitna rrrntrtlenlena-pfh aptl Tdtieavsk hiah frait riio iulstgltn edeifwee t apac eiaha . ssrparsay L o iet ttw owtggadyhenoiolt whs.oeea k fbmkcyh al a i lge nel

saa eo etea.teeeeytntpv aesPer)aperteqlnreh (rrsi ounabtaldse re t omdfnls' t uet etnLpvc

sni,s gfs"calitLs oei u Aa, ewF aeaaelfo ,p rhvot tkenesstte el smsgoyuygrwy"ro ooete yLt(lciomfe o yuts, redh Lmhtluironeup"orh o t eutv se i ka iftsbd d"noNu neousrho ss trtdeie)pce hots aphcr ssoia oir alrbh mmauiirarle sn ,tnimnindayteyeotc..ne efteo lIss.,bhaoueeynhitdeysale l o aeeaysv eheaagrhtthow othtuernnly aa o r ,riprDvdoea aael